Weight reduction has been shown to alleviate symptoms of osteoarthritis of the knee, including pain. The effect of ...

People who lost a significant amount of weight with semaglutide saw major improvements in osteoarthritis knee pain, research published Wednesday in the New England Journal of Medicine finds.

A large trial showed that semaglutide, sold as Ozempic for diabetes and as Wegovy for obesity, was better than any current ...

Same Active Ingredient as other “Weight Loss” Meds Without the High Price Reef Family Pharmacy proudly announces a choice of ...

Hims & Hers (HIMS) stock fell 14% following news that Novo Nordisk’s (NVO) weight-loss drug Wegovy is no longer ...

Semaglutide (Wegovy) reduced pain and improved physical function in patients with obesity and knee osteoarthritis, a ...

Clinical-trial participants saw their knee pain abate and could engage better with activities that got them up and going.

Researchers have found "tremendous long-term outcomes" for teenagers who underwent surgery to treat their severe obesity a ...

In this case report, Gad and colleagues performed corneal confocal microscopy to assess for evidence of nerve regeneration ...

The diabetes and weight loss medications Ozempic and Wegovy are now considered to be available after more than two years ...

Topline results were announced from a cardiovascular outcomes study evaluating oral semaglutide in patients with type 2 diabetes.